The end-stage renal disease (ESRD) Medicare reform measures recently passed by Congress represent the most significant ESRD reforms in decades. These measures and how they will impact the practice of nephrology and patient care will be the topic of a session during the American Society of Nephrology (ASN) 41st Annual Meeting and Scientific Exposition in
Full Post: Impact of end-stage renal disease (ESRD) Medicare reform explained
Following yesterday’s release of the Competition Bureau’s report, “Benefiting from Generic Drug Competition in Canada: The Way Forward,” the Ontario Pharmacists’ Association (OPA) is emphasizing that competition in the generic drugs industry is already benefiting Ontarians through accessible, high quality, cost-effective professional pharmacy care.
“The current pharmacy funding model in Ontario is feasible because professional allowances provided to pharmacies by generic drug manufacturers subsidize the provision of dispensing services,” said Dennis Darby, Chief Executive Officer of OPA.
“These professional allowances also help pharmacists provide other pharmacy professional services such as continuing education programs; clinic days including flu shot, asthma clinics and diabetes management clinics; public education days for health protection and promotion activities; compliance packaging that assists patients with complicated medication regimes; disease management and prevention initiatives such as patient information material and services, blood pressure monitoring, blood glucose meter training, asthma management and smoking cessation; private counseling areas; and hospital in-patient or long-term care home resident clinical pharmacy services, such as medication reconciliation initiatives.”
In Ontario, the role that professional allowances play was addressed in the Transparent Drug Systems for Patients Act, 2006. The Act requires pharmacies to use professional allowances for direct patient care, and report regularly to government on how these funds are being used.
Currently, the funding received for pharmacy services from public or private drug plans is much lower than the cost to pharmacies for providing those services.
The “Costs of Ontario Community Pharmacy Services - 2008″ study of 505 community pharmacies in the province found the median cost to provide pharmacy services was $13.77 per prescription. By comparison, Ontario Drug Benefit Program (ODBP) pharmacy compensation averages $8.70 per prescription, according to current data.(1)
“The current framework for the compensation of pharmacy services is not sustainable or economically viable and needs to be modernized,” Darby said. “OPA and other organizations are working closely with the Ontario government and others to find solutions that will enable pharmacists to continue to provide the best care possible for patients.”
The Ontario Pharmacists’ Association is the professional advocacy association representing the views and interests of more than 11,000 practicing pharmacists and pharmacists-in-training.
http://www.opatoday.com
--------------------------------------------------------------------------------------------
Related Posts:
Just like saving money on groceries or finding the best deal on gas, smart consumers can cut their prescription drug costs with just a little bit of work, say pharmacists at the University of North Carolina at Chapel Hill. Stefanie Ferreri, Pharm.D., and Jena Ivey, Pharm.D., both practicing pharmacists and clinical assistant professors at the
Full Post: Good advice to cut prescription drug costs
LegitScript, an online pharmacy certification program, announced today that it has succeeded in getting nearly 500 “rogue” Internet pharmacy websites shut down. The sites had been selling prescription drugs or steroids without requiring a prescription, a practice that is illegal and considered unsafe by medical authorities. In most cases, the drugs were sold from outside
Full Post: LegitScript shuts down 500 no-prescription-required online pharmacies
New research from the Royal Pharmaceutical Society of Great Britain (RPSGB) could shed light on the reasons behind the poor state of men’s health in Britain. The RPSGB commissioned study, designed to discover how men’s attitudes might affect their healthcare, revealed that 59% of men are reluctant to ask for help and only seek medical
Full Post: Men’s health - the facts
When you sit down with your physician and discuss treatment, cost is always something on your mind. An operation can be a single big ticket item, but more often it is the daily doses of a must-have medication that slowly wears away your financial security. A drug like lexapro may be recommended over a period
Full Post: Find affordable drugs by comparing prices online
The Food and Drug Administration within the U.S. Department of Health and Human Services (HHS) has reached the milestone of the 75th anti-retroviral generic drug approved or tentatively approved as part of President Bush’s Emergency Plan for AIDS Relief (PEPFAR). Marketed by Macleods Pharmaceuticals, Ltd, of Kachigam, Daman, in the Republic of India, the
Full Post: FDA grants tentative approval for 75th generic anti-retroviral drug --------------------------------------------------------------------------------------------
